Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Nugraf (filgrastim biosimilar)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Zenotech

Drug class:

G-CSF stimulant

Related drugs:

No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2	cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive: A2 - Guideline cytarabine + mitoxantrone + cladribine + Nugraf (filgrastim biosimilar) Sensitive : A2